Quantum BioPharma Ltd. - Ordinary Shares - Class B (Sub Voting)
QNTM
Market Cap$8.54M
Close$
$3.29
90.6% downside
Current Fair Value
90.6% downsideOvervalued by 90.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $8.54 Million |
|---|---|
| Enterprise Value | $7.30 Million |
| Dividend Yield | $0 (-%) |
| Earnings per Share | $- |
| Beta | 0.83 |
| Outstanding Shares | - |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.35 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.31 |
| Debt to Equity | 0.4 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Quantum BioPharma Ltd.
5 employees
CEO: Raza Bokhari fsd pharma inc., through its subsidiary, fv pharma inc., produces medical cannabis in canada. the company focuses on the development of indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based...